McKesson Corporation (MCK)Officer sold ~$2.06M
Thomas L Rodgers, Officer at McKesson Corporation, sold ~$2.06M of McKesson Corporation shares.
- ~$2.06M
- Approx. value · 2,891 sh @ $712.18
- 2,544
- Holds after · shares reported
- Traded
- May 30, 2025
- Filed
- Jun 2, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 24, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
- Apr 9, 2025CongressDisclosed partial sale of MCK — reported range $1,001 - $15,000
- Apr 23, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
- Apr 24, 2025FDARecall: SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET.
- Apr 24, 2025FDARecall: ABBOTT POINT OF CARE TEST CREA I-STAT (25/BX) ABBTPT CARTRIDGE.
- Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC ANTI-B BIOCLONE 10ML3X10ML.
- Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC VITROS BUN (60/CR 5CR/PK) ORCLNL REAGENT.
- Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCH AUSAB ANTI-HBS (100/EA) REAGENT.
- Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCHITECT PROGESTERONE (100TESTS) REAGENT.
- Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCHITECT FREE T4ABBDIA CALIBRATOR.
- Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARC ANTI-TPO ASSAY 100TST B REAGENT.
- Apr 24, 2025FDARecall: ABBOTT RAPID DX N AMERICA LLC, TEST CHOLESTEC LDXLIPID PROFILE (10/BX 50BX/CS) CASSETTES.
- Apr 24, 2025FDARecall: HEMOCUE INC GLUC AQUEOUS 1HI/LO HEMCUE CONTROL KIT.
- Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC VITROS CALCIUM (L-SEQUESTER) (300/PK) REAGENT.
- Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARC CARBON DIOXIDE6X5ML B CALIBRATOR.
- Apr 25, 2025FDARecall: Infuvite Adult, multiple vitamins injection, Baxter, Five of Vial 1 (5 mL) and Five of Vial 2 (5mL), Rx Only, Sterile, Manufactured for: Sandoz Inc., Princeton…
- Apr 25, 2025FDARecall: Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC…
- Apr 29, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
- May 12, 2025CongressDisclosed sale of MCK — reported range $15,001 - $50,000
- May 19, 2025InsiderOfficer sold ~$394K of MCK shares in the open market
- May 22, 2025Insider · 2 peopleInsiders: 2 sales (~$5.4M)
- May 23, 2025Insider · 3 peopleInsiders: 3 sales (~$684K)
- May 27, 2025InsiderOfficer sold ~$704K of MCK shares in the open market
- May 28, 2025Insider · 4 peopleInsiders: 4 sales (~$2.0M)
- May 30, 2025 · this disclosureInsiderOfficer sold ~$2.06M of MCK shares in the open market
What came next
- Jun 6, 2025InsiderCEO sold ~$13.7M of MCK shares in the open market
- Jul 11, 2025InsiderCEO sold ~$13.7M of MCK shares in the open market
- Jul 11, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
- Jul 30, 2025FDARecall: Clearview Strep A Exact II Dipstick Respiratory Kit, CLIA Waived. Catalog Number: 4581225020
- Aug 5, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
- Aug 8, 2025InsiderOfficer sold ~$218K of MCK shares in the open market
- Aug 15, 2025InsiderCEO sold ~$8.09M of MCK shares in the open market
- Aug 22, 2025InsiderCEO sold ~$8.42M of MCK shares in the open market
- Sep 18, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for McKesson Corporation
For McKesson Corporation, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 47 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.
Other recent filings by Thomas L Rodgers, EVP, Chief Strategy & BDO
- SEC Form 4 at McKesson Corporation (MCK)Jun 3, 2026
- SEC Form 4 at McKesson Corporation (MCK)Jun 3, 2026
- SEC Form 4 at McKesson Corporation (MCK)May 27, 2026
- SEC Form 4 at McKesson Corporation (MCK)Jan 6, 2026
- SEC Form 4 at McKesson Corporation (MCK)May 29, 2025
The full history of Thomas L Rodgers, EVP, Chief Strategy & BDO is on the profile page.
How this filing works
Other disclosures at McKesson Corporation
- USAspending.gov award recordOct 5, 2026
- SEC Form 4Sep 10, 2026
- USAspending.gov award recordSep 4, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its MCK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
